First-in-human (FIH), pharmacokinetic (PK) and pharmacodynamic (PD) study of IOA-244, a phosphoinositide 3-kinase delta (PI3K delta) inhibitor, in patients with advanced metastatic mesothelioma, uveal and cutaneous melanoma

Di Giacomo, AM (author)

Santangelo, F (author)

Amato, G (author)

show more...

Simonetti, E (author)

Graham, J (author)

Lahn, M (author)

Zorilla, R (author)

van der Veen, L (author)

Johnson, Z (author)

Pickering, C (author)

Marechal, E (author)

Blanco, J (author)

Blanco, J (author)

Durini, M (author)

Gufford, B (author)

Lakshmikanth, T (author)

Brodin, P (author)

Spiliopoulou, P (author)

Evans, TRJ (author)

Maio, M (author)

show less...

Elsevier BV, 2021

2021

English.

In: ANNALS OF ONCOLOGY. - : Elsevier BV. - 0923-7534. ; 32, s. S1438-S1438

Related links:

http://www.annalsofo...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Conference paper (other academic/artistic)